Amor B, Georgiadis A, Kahan A, Delbarre F
Pathol Biol (Paris). 1978 Sep;26(6):377-80.
In patients with ankylosing spondylitis (AS) the plasma level of beta2-microglobulin (beta2m) is signficantly higher (1.95 +/- 0.48 mg/l) than in osteoarthritis (1.48 +/- 0.47 mg/l). In Reiter's syndrome the level of beta2m is also higher than in controls, but the paucity of results do not allow definite conclusions. The plasma level of beta2m in AS and in Reiter's syndrome is not related to the presence of HLA B 27 antigen, neither to other biological parameters as sedimentaton rate, blood cell counts, electrophoresis of plasma proteins. In rheumatoid arthritis the plasma level of beta2m is 2,67 +/- 0.84 mg/l, significantly higher than in osteoarthritis or in AS even without any association with Sjögren's syndrome. In synovial fluid, the beta2m level is closely related to the degree of inflammation, suggesting a local production of this substance.
在强直性脊柱炎(AS)患者中,β2-微球蛋白(β2m)的血浆水平(1.95±0.48mg/l)显著高于骨关节炎患者(1.48±0.47mg/l)。在赖特综合征中,β2m水平也高于对照组,但结果数量较少,无法得出明确结论。AS和赖特综合征患者的血浆β2m水平与HLA B 27抗原的存在无关,也与其他生物学参数如血沉、血细胞计数、血浆蛋白电泳无关。在类风湿关节炎中,血浆β2m水平为2.67±0.84mg/l,即使与干燥综合征无任何关联,也显著高于骨关节炎或AS患者。在滑液中,β2m水平与炎症程度密切相关,提示该物质为局部产生。